diazepam injection, USP - CARPUJECT Principal Display Panel | Pfizer Medical Information - US

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PRINCIPAL DISPLAY PANEL - 2 mL Cartridge Label

2 mL Single-dose Carpuject™
Sterile Cartridge Unit with Luer Lock
Rx only
NDC 0409-1273-03

Diazepam Injection, USP
CIV

PAA132815

10 mg/2 mL (5 mg/mL)

For Intramuscular Or Intravenous Use. Protect from light.

Distributed by
Hospira, Inc., Lake Forest, IL 60045 USA

Hospira

LOT #####AA
EXP DMMMYYYY

PRINCIPAL DISPLAY PANEL - 2 mL Cartridge Label

PRINCIPAL DISPLAY PANEL - 2 mL Cartridge Carton

NDC 0409-1273-32
Contains 10 of NDC 0409-1273-03

2 mL Single-dose
10 Carpuject™
Sterile Cartridge Units
with Luer Lock

Needle not included
SLIM-PAK™
Tamper Detection Package

Diazepam
Injection, USP
CIV

10 mg/2 mL
(5 mg/mL)

For Intramuscular Or
Intravenous Use

Carpuject Cartridges are to be
used ONLY with Carpuject Holders.

Hospira

PRINCIPAL DISPLAY PANEL - 2 mL Cartridge Carton

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

diazepam injection, USP - CARPUJECT Quick Finder

Pfizer samples (for eligible HCPs)

Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426 or by visiting the PfizerPro website www.pfizerpro.com.
Report an adverse event or concern about the quality of a Pfizer product

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly by visiting www.fda.gov/medwatch or by calling (800)-332-1088.
Assistance programs (for eligible patients)

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Patients and physicians can contact RxPathways at (866) 706-2400 or visit the website for more information on these programs www.pfizerrxpathways.com.
Resources

Show All Hide All

WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS

•: Concomitant use of benzodiazepines and opioids may result in profound sedation,...

Read more

Did you find an answer to your question? Yes No

INDICATIONS AND USAGE

Diazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not...

Read more

Did you find an answer to your question? Yes No

DOSAGE AND ADMINISTRATION

Dosage should be individualized for maximum beneficial effect. The usual recommended dose in older children and adults ranges from 2 mg to 20 mg IM or IV, depending on the indication and its...

Read more

Did you find an answer to your question? Yes No

CONTRAINDICATIONS

Diazepam Injection is contraindicated in patients with a known hypersensitivity to this drug; acute narrow angle glaucoma; and open angle glaucoma unless patients are receiving appropriate therapy.

Read more

Did you find an answer to your question? Yes No

WARNINGS

Risks from Concomitant Use with Opioids

Concomitant use of benzodiazepines, including diazepam, and opioids may result in profound sedation, respiratory...

Read more

Did you find an answer to your question? Yes No

ADVERSE REACTIONS

Side effects most commonly reported were drowsiness, fatigue, and ataxia; venous thrombosis and phlebitis at the site of injection. Other adverse reactions less frequently reported include:

...

Read more

Did you find an answer to your question? Yes No

DRUG ABUSE AND DEPENDENCE

Controlled Substance

Diazepam Injection is a schedule IV controlled substance.

...

Read more

Did you find an answer to your question? Yes No

OVERDOSAGE

Overdosage of benzodiazepines is characterized by central nervous system depression ranging from drowsiness to coma. In mild to moderate cases, symptoms can include drowsiness, confusion, dysarthria, lethargy,...

Read more

Did you find an answer to your question? Yes No

DESCRIPTION

Diazepam Injection, USP is a sterile, nonpyrogenic solution intended for intramuscular or intravenous administration. Each milliliter (mL) contains 5 mg diazepam; 40% propylene glycol; 10% alcohol; 5% sodium...

Read more

Did you find an answer to your question? Yes No

CLINICAL PHARMACOLOGY

In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable...

Read more

Did you find an answer to your question? Yes No

ANIMAL PHARMACOLOGY

Oral LD50 of diazepam is 720 mg/kg in mice and 1240 mg/kg in rats. Intraperitoneal administration of 400 mg/kg to a monkey resulted in death on the sixth day.

...

Read more

Did you find an answer to your question? Yes No

HOW SUPPLIED

Carpuject™ Sterile Cartridge Unit with Luer Lock

...

Read more

Did you find an answer to your question? Yes No

CIV

Rx only

Diazepam...

Read more

Did you find an answer to your question? Yes No

Did you find an answer to your question? Yes No

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985^*

*Contact Medical Information.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at
(800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatchor by calling
(800)-332-1088.